EOLS
Evolus Inc
Price:  
9.48 
USD
Volume:  
852,343.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS Relative Valuation

-277.5%
Upside

As of 2025-07-14, the Relative Valuation of Evolus Inc (EOLS) is (16.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.48 USD, the upside of Evolus Inc based on Relative Valuation is -277.5%.

The range of the Relative Valuation is (16.86) - (16.07) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.5x - 18.4x 18.0x
Forward P/E multiples 19.3x - 22.2x 20.6x
Fair Price (16.86) - (16.07) (16.82)
Upside -277.8% - -269.5% -277.5%
9.48 USD
Stock Price
(16.82) USD
Fair Price

EOLS Relative Valuation - Historical P/E Data

Date P/E
2025-07-11 -10.88
2025-07-10 -11.16
2025-07-09 -11.08
2025-07-08 -10.62
2025-07-07 -10.49
2025-07-03 -10.64
2025-07-02 -10.57
2025-07-01 -10.55
2025-06-30 -10.57
2025-06-27 -10.49
2025-06-26 -10.68
2025-06-25 -10.44
2025-06-24 -11.04
2025-06-23 -10.76
2025-06-20 -10.65
2025-06-18 -10.67
2025-06-17 -10.61
2025-06-16 -11.43
2025-06-13 -11.39
2025-06-12 -11.68
2025-06-11 -11.75
2025-06-10 -11.32
2025-06-09 -11.07
2025-06-06 -11.52
2025-06-05 -11.17
2025-06-04 -11.24
2025-06-03 -11.43
2025-06-02 -11.44
2025-05-30 -10.54
2025-05-29 -10.72
2025-05-28 -10.67
2025-05-27 -11.25
2025-05-23 -11.11
2025-05-22 -10.97
2025-05-21 -11.00
2025-05-20 -11.43
2025-05-19 -11.36
2025-05-16 -11.13
2025-05-15 -11.47
2025-05-14 -11.46
2025-05-13 -11.62
2025-05-12 -11.45
2025-05-09 -11.24
2025-05-08 -11.58
2025-05-07 -13.49
2025-05-06 -13.32
2025-05-05 -13.78
2025-05-02 -13.86
2025-05-01 -13.54
2025-04-30 -13.08